» Articles » PMID: 22605691

Morbid Obesity in a Child with Monosomy 1p36 Syndrome

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2012 May 19
PMID 22605691
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The monosomy 1p36 syndrome is a cause of syndromic obesity. It is characterised by psychomotor delay, hypotonia and typical craniofacial dysmorphism. Other features commonly associated are behavioural anomalies including hyperphagia and self-injuring, seizures, congenital heart disease and hypothyroidism. The authors report the case of a 9-year and 5-month-boy referred to the paediatric endocrinology clinics for morbid obesity. Clinical findings were generalised obesity with a body mass index >95th centile, acanthosis nigricans of the neck, arms with self inflicted lesions, deep-set eyes, straight eyebrows, broad nasal bridge and pointed chin. He was unable to walk and had no expressive language. Cytogenetic analysis identified 1p36.33-pter deletion (~139 Mb terminal deletion in chromosome 1 short arm) and Y chromosome duplication. The blood analysis showed insulin resistance and dyslipidaemia. The authors emphasise the need to consider monosomy 1p36 as a cause of severe psychomotor delay and obesity.

Citing Articles

Chromosome 1p36 Deletion Syndrome: Four Patients with Variable Presentations.

Chaudhry C, Kumari D, Panigrahi I, Kaur P J Pediatr Genet. 2024; 12(4):342-347.

PMID: 38162157 PMC: 10756721. DOI: 10.1055/s-0041-1732477.


CTRP12 inhibits triglyceride synthesis and export in hepatocytes by suppressing HNF-4α and DGAT2 expression.

Tan S, Little H, Sarver D, Watkins P, Wong G FEBS Lett. 2020; 594(19):3227-3239.

PMID: 32749667 PMC: 7722243. DOI: 10.1002/1873-3468.13895.


Partial deficiency of CTRP12 alters hepatic lipid metabolism.

Tan S, Little H, Lei X, Li S, Rodriguez S, Wong G Physiol Genomics. 2016; 48(12):936-949.

PMID: 27815536 PMC: 5206390. DOI: 10.1152/physiolgenomics.00111.2016.


Identification of 1p36 deletion syndrome in patients with facial dysmorphism and developmental delay.

Seo G, Kim J, Cho J, Kim G, Seo E, Lee B Korean J Pediatr. 2016; 59(1):16-23.

PMID: 26893599 PMC: 4753195. DOI: 10.3345/kjp.2016.59.1.16.

References
1.
McCrindle B, Urbina E, Dennison B, Jacobson M, Steinberger J, Rocchini A . Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with.... Circulation. 2007; 115(14):1948-67. DOI: 10.1161/CIRCULATIONAHA.107.181946. View

2.
Rosenfeld J, Crolla J, Tomkins S, Bader P, Morrow B, Gorski J . Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions. Am J Med Genet A. 2010; 152A(8):1951-9. DOI: 10.1002/ajmg.a.33516. View

3.
DAngelo C, Kohl I, Varela M, de Castro C, Kim C, Bertola D . Extending the phenotype of monosomy 1p36 syndrome and mapping of a critical region for obesity and hyperphagia. Am J Med Genet A. 2009; 152A(1):102-10. DOI: 10.1002/ajmg.a.33160. View

4.
Stochholm K, Juul S, Gravholt C . Diagnosis and mortality in 47,XYY persons: a registry study. Orphanet J Rare Dis. 2010; 5:15. PMC: 2889887. DOI: 10.1186/1750-1172-5-15. View

5.
Battaglia A, Hoyme H, Dallapiccola B, Zackai E, Hudgins L, McDonald-McGinn D . Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics. 2008; 121(2):404-10. DOI: 10.1542/peds.2007-0929. View